Private Equity, VC & Investor
Foresight Group vs M&G
Structured technology and market comparison · 2026
Direct Feature Comparison
Foresight Group · vs · M&GPublic investment manager specialising in real assets and private equity.
UK savings, insurance and asset management group.
Analyze all overlapping signals and tech stacks for Foresight Group and M&G
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Foresight Group and M&G?
When comparing Foresight Group and M&G, both platforms operate within the Private Equity, VC & Investor ecosystem. Foresight Group is positioned as Public investment manager specialising in real assets and private equity, whereas M&G focuses on UK savings, insurance and asset management group. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Foresight Group and M&G?
When evaluating Foresight Group and M&G, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Foresight Group and M&G compare?
Foresight Group is headquartered in United Kingdom (founded in 1984) with 201–500 employees. M&G is based in United Kingdom (founded in 2017) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Foresight Group vs M&G
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Foresight Group
Recent Signals
- ·Foresight Group
Foresight Group announces acquisition of Blackhillock Synchronous Condenser
The acquisition marks Foresight’s entry into the dedicated long-term grid stability market, complementing its extensive portfolio of renewables and battery storage assets.
- ·Foresight Group
Foresight invests in Distology to support next phase of growth
Foresight Group announces a new investment in Distology to support its next phase of growth, as highlighted in the latest news section.
M&G
Recent Signals
- ·Tech.eu (European Tech & Deals)Financials
bit.bio Raises $25M Series D for Cell Models
bit.bio, a human cell programming company, announced it has closed a $25 million Series D funding round. The investment will be used to expand its portfolio of human cell models and increase access to its technology for pharmaceutical, biotechnology, and research organizations. The round includes participation from existing investor M&G Investments and Dr Jonathan Milner, founder and former CEO of Abcam. The company's opti-ox™ platform enables the production of defined human cell types at scale, and its ioCells portfolio includes over 50 cell types for drug discovery and disease research. The funding comes as AI accelerates drug candidate identification and there is growing demand for alternatives to animal testing.
- bit.bio closed a $25 million Series D funding round.
- The round includes participation from M&G Investments and Dr Jonathan Milner.
- bit.bio's opti-ox™ platform enables scalable production of defined human cell types.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Foresight Group and M&G share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks